NCT03772145View on ClinicalTrials.gov

Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

TerminatedOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

November 27, 2018

Primary Completion Date

January 29, 2023

Study Completion Date

January 29, 2024

Conditions

Ulcerative Colitis

Trial Locations (1)

27599

Division of Gastroenterology and Hepatology, Chapel Hill

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

University of North Carolina, Chapel Hill

OTHER